-
cds.ahrq.gov/cdsconnect/artifact/uspstf-aspirin-therapy-primary-prevention-cardiovascular-disease
July 10, 2017 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
April 01, 2021 - Calculation of updated risk after preventive therapies have been initiated. … , aspirin therapy, and/or smoking
cessation were to be initiated. … , blood pressure control, and statin therapy, if these have not already been started. … “one or more
therapies”
One or more of the following: smoking cessation, hypertension treatment, statin … therapy,
or aspirin therapy.
21
Artifact Development Decision Log
The Artifact Development
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
October 01, 2017 - Calculation of updated risk after preventive therapies have been initiated. … Define “treatment for hypertension” as the existence of an active antihypertensive medication in the … value sets created in support of PQRS#438 Statin Therapy for the Prevention and Treatment of CVD.
9. … "preventive therapies"
One or more of the following: smoking cessation, hypertension treatment, statin … therapy or aspirin therapy.
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
January 01, 2010 - Calculation of updated risk after preventive therapies have been initiated. … HDL) cholesterol, systolic blood
pressure, smoking within the past year, presence of diabetes, and treatment … OR statin therapy
OR blood pressure therapy
OR smoking cessation
Note for further development … “preventive
therapies”
One or more of the following: smoking cessation, hypertension treatment, statin … therapy, or
aspirin therapy.
-
cds.ahrq.gov/sites/default/files/workgroups/33746/CDS_Connect_WG_Presentation_September_2021.pdf
January 01, 2021 - options for easier maintenance
• Not visible to users
15
CDS Artifacts (Slide 1 of 2)
• Statin Therapy … for the Prevention and Treatment of Cardiovascular Disease (CVD) eCQM
► Aligned with latest version … evidence, per USPSTF; Value sets updated; CQL updated for R4; metadata updated with posted IG
• Aspirin Therapy … applicable; metadata updated with the posted IG
16
https://cds.ahrq.gov/cdsconnect/artifact/statin-therapy-prevention-and-treatment-cardiovascular-disease-cvd-ecqm … statin-use-primary-prevention-cvd-adults-patient-facing-cds-intervention
https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer
-
cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
January 01, 2017 - .
· Statin therapy exclusions:
· Pregnant, breastfeeding, cirrhosis, end stage renal disease, and hemodialysis … patient with a past rhabdomyolysis diagnosis due to a previous fall shouldn’t be excluded from a statin therapy … disease other than cirrhosis, e.g. fatty liver disease, shouldn’t be automatically excluded from statin therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Implementation Guide
USPSTF Aspirin Therapy for the Primary Prevention … USPSTF Aspirin Therapy for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer iii … Implementation Guide: USPSTF Aspirin Therapy for the Primary Prevention of Cardiovascular Disease and … If the patient has CVD/ASCVD a different treatment may be indicated. … If the patient has CRC a different therapy may be indicated.
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
September 01, 2021 - Calculation of updated risk after preventive therapies have been initiated. … with statin therapy or aspirin therapy prior to changing or initiating
therapy. … Implementation
guidance
“LDL,” “Statin
Therapy,” and
“Aspirin Therapy”
The concepts of LDL, … statin therapy, and aspirin therapy are not required or evaluated
against to determine baseline ASCVD … with statin therapy or aspirin therapy prior to
changing or initiating therapy by adding to the CQL
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
October 01, 2017 - Calculation of updated risk after preventive therapies have been initiated. … , blood pressure control, and statin therapy, if these have not already been started. … , aspirin therapy, and/or smoking cessation were to be initiated. … Define “treatment for hypertension” as the existence of an active antihypertensive medication in the … "
One or more of the following: smoking cessation, hypertension treatment, statin therapy, or aspirin
-
cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
January 01, 2017 - · Discuss Remaining Repository Questions
· Clarify 10-Year Risk Assessment Details
· Discuss Statin Therapy … for the Prevention and Treatment of CVD eCQM/CDS Artifact
· Discuss Next Artifacts for Development
· … Discuss Statin Therapy for the Prevention and Treatment of CVD eCQM/CDS Artifact
Quality Insights of … They provided an overview of a statin therapy measure available as a registry measure under the Physician … Discuss Statin Therapy for the Prevention and Treatment of CVD eCQM/CDS Artifact
Not discussed.
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
February 01, 2018 - Calculation of updated risk after preventive therapies have been initiated. … with statin therapy or aspirin therapy prior to
changing or initiating therapy. … Implementation
guidance
“LDL”, “Statin
Therapy” and “Aspirin
Therapy”
The concepts of LDL, statin … therapy, and aspirin therapy are not required or evaluated against to
determine baseline ASCVD risk … with statin therapy or aspirin therapy prior to changing or initiating therapy by adding
to the CQL
-
cds.ahrq.gov/sites/default/files/cds/artifact/686/Clostridium%20difficile%20(C.diff)%20Infection%20Treatment%20Pathway_updated%20March%202019.pdf
January 01, 1970 - diarrhea within 5 DAYS
Sepsis recognition tool
Start vancomycin tapered regimen
after completing therapy
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
January 01, 2024 - treatment decisions. … nonopioid pharmacologic therapy for the
treatment of pain, as well as additional complex factors to … Intervention
“Nonopioid pain
medication”
Medications with analgesic effects that may provide therapeutic … ”
Nonmedication procedures and therapies employed to treat pain (e.g., physical therapy, massage, … updated in 2023, with several therapies now showing evidence of
benefit in the 2022 AHRQ systematic
-
cds.ahrq.gov/sites/default/files/workgroups/71451/CDS_Connect_WG_March_2022_Presentation.pdf
January 01, 2022 - discourage the use of
this service”
• New logic, but highly related to existing CDS artifact Aspirin Therapy … 10
https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
January 01, 2024 - and patients decide on the use of aspirin therapy to
mitigate the patient’s risk of developing CVD … At a very high level, the interventions and
recommendations pertinent to the Aspirin Therapy artifact … Evidence Source for Artifact Development
The Aspirin Therapy artifact is derived from the Aspirin Use … Decision Log
Artifact Semistructured Logic
The Aspirin Therapy artifact is derived from the Aspirin … If the patient
has CVD/ASCVD, then a different treatment may be indicated.
-
cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
November 11, 2019 - Use only if benefit outweighs risk
· Rationale: Increased bleeding risk likely
Name of PDDIStatin Therapy … for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality Measure 6
Version … for the Prevention and Treatment of Cardiovascular Disease (CVD) Electronic Clinical Quality Measure … How Artifact Operates Within CQL
The Statin Therapy for the Prevention and Treatment of Cardiovascular … for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality Measure 12
Version
-
cds.ahrq.gov/sites/default/files/cds/artifact/136331/Bisphosphonates%20Patient%20Handout.pdf
July 18, 2023 - This medication is taken:
Adapted from "Patient Fact Sheet - Bisphosphonate Therapy", American College
-
cds.ahrq.gov/sites/default/files/cds/artifact/66551/Bisphosphonates%20Patient%20Handout.pdf
July 18, 2023 - This medication is taken:
Adapted from "Patient Fact Sheet - Bisphosphonate Therapy", American College
-
cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
August 29, 2020 - outweighs risk
· Rationale: Increased GI and non-GI bleeding risk is likely
Name of PDDIStatin Therapy … for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality Measure 6
Version … for the Prevention and Treatment of Cardiovascular Disease (CVD) Electronic Clinical Quality Measure … How Artifact Operates Within CQL
The Statin Therapy for the Prevention and Treatment of Cardiovascular … for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality Measure 12
Version
-
cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
June 07, 2019 - The artifact is a CDS rule
representation of CDC clinical guidance for antimicrobial therapy and anthrax … This CDS uses the overarching ingredient code for the
antimicrobial therapy [12].
5. … Second, because PEP requires 60 days of antimicrobial therapy and three vaccines administered
at least … and levels of physical and/or cognitive impairment; and issues
related to the specific medication therapy … FHIR
resources that contain ingredient/substance codes for any of the potentially recommended
PEP treatments